Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation

Clinical trial NCT06634056 · RECRUITING

Trial details

NCT number: NCT06634056
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Radiation Induced Lung Injury (RILI)

Start date: 2026-06-15
Primary completion: 2031-11-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.